Loading...
•
Mar 31, 2024
ClearPoint Neuro Q1 2024 Earnings Report
ClearPoint Neuro achieved record revenue and strategic progress.
Key Takeaways
ClearPoint Neuro reported a strong first quarter in 2024, achieving record revenue of $7.6 million, a 41% year-over-year increase. The company saw significant growth in biologics and drug delivery revenue, as well as capital equipment sales, and reduced its operational cash burn.
Reported quarterly revenue of $7.6 million, a 41% year-over-year increase.
Increased biologics and drug delivery revenue to $4.3 million, a 61% year-over-year increase.
Activated eight new hospital customers, a new Company record for a quarter.
Operational cash burn reduced to $3.8 million, a 32% year-over-year decrease.
Revenue by Segment
Forward Guidance
The Company reaffirms its full year 2024 revenue outlook of between $28.0 and $32.0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...